The Human Disharmony Loop Clinical Presentation. by James M. Friedman (22522150)

Subjects:

Patient Demographics. by James M. Friedman (22522150)

Subjects:

Pain and Function Outcomes Following PM Tenotomy. by James M. Friedman (22522150)

Subjects:

Diagnostic Criteria for Human Disharmony Loop. by James M. Friedman (22522150)

Subjects:

Normal Anatomy vs. Disharmonic Pathoanatomy. by James M. Friedman (22522150)

Subjects:

Sample Pain Diagrams. by James M. Friedman (22522150)

Subjects:

Patient Example. by James M. Friedman (22522150)

Subjects:

S1 Data - by James Anaba Akolgo (14129379)

Subjects:

Elasticity and return to scale. by James Anaba Akolgo (14129379)

Subjects:

Standardized prevalence* HADS-D>=8 with 95% CI by sex, time, age group, and living situation. by Maria Lage Barca (4515385)

Subjects:

Standardized** prevalence of depression (HADS-D>=8) with 95% CI by sex and year, age 70 + . by Maria Lage Barca (4515385)

Subjects:

Standardized prevalence of depression (HADS-D>=8 with 95% CI) by sex, time, and age group. by Maria Lage Barca (4515385)

Subjects:

Standardized prevalence* of depression (HADS-D>=8) with 95% CI by sex, age, and self-reported loneliness. by Maria Lage Barca (4515385)

Subjects:

Primer sequences for RT-qPCR. by Wenlong Shen (9313937)

Subjects:

siRNA sequences and negative controls sequences. by Wenlong Shen (9313937)

Subjects:

Antibodies used in the study. by Wenlong Shen (9313937)

Subjects:

Changes in the monthly contamination rate (per set) in blood culture (BC). by Miki Doi (15347878)

Subjects:

Patient background and blood culture-related factors before and after revision of the blood culture collection protocol. by Miki Doi (15347878)

Subjects:

Comparison of the blood culture contamination rate (per set) in each organism between the control and bundle periods. by Miki Doi (15347878)

Subjects:

Reasons for the determination of blood culture contamination for each organism. by Miki Doi (15347878)

Subjects: